Literature DB >> 26884895

Clinical modalities for management of gastric cancer hepatic metastasis.

Feng Tao1, Jieqing Lv1, Wei Wang1, Ketao Jin1.   

Abstract

The best treatment for gastric cancer hepatic metastasis is still widely debated. Gastric cancer hepatic metastases has long been justified the indication of palliative chemotherapy. Inspired by the good results of the management of colorectal cancer hepatic metastases, surgeons have focused on the curative or palliative treatment of gastric cancer hepatic metastases. The current clinical modalities used for treatment of gastric cancer hepatic metastasis include liver resection, systemic chemotherapy, radiofrequency ablation (RFA), hepatic arterial infusion (HAI), and palliative gastrectomy. This article presents a review of the literature on hepatic resection, RFA, HAI, palliative gastrectomy, and systemic chemotherapy for the treatment of liver metastases in gastric carcinoma, and discusses the indications and long-term results.

Entities:  

Keywords:  Gastric cancer; hepatic arterial infusion (HAI); hepatic metastases; liver resection; palliative gastrectomy; radiofrequency ablation (RFA); systemic chemotherapy

Year:  2015        PMID: 26884895      PMCID: PMC4723740     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  74 in total

1.  Prospective study of arterial infusion chemotherapy followed by radiofrequency ablation for the treatment of liver metastasis of gastric cancer.

Authors:  Koichiro Yamakado; Atsuhiro Nakatsuka; Haruyuki Takaki; Yasuhiro Mori; Hitoshi Tonouchi; Masato Kusunoki; Hideya Kida; Kan Takeda
Journal:  J Vasc Interv Radiol       Date:  2005-12       Impact factor: 3.464

2.  Phase II study of combined administration of 5-fluorouracil, epirubicin and mitomycin-C by hepatic artery infusion in patients with liver metastases of gastric cancer.

Authors:  T Kumada; Y Arai; K Itoh; Y Takayasu; K Nakamura; Y Ariyoshi; K Tajima
Journal:  Oncology       Date:  1999-10       Impact factor: 2.935

3.  Outcome after simultaneous resection of gastric primary tumour and synchronous liver metastases: survival analysis of a single-center experience in China.

Authors:  Qian Liu; Jian-Jun Bi; Yan-Tao Tian; Qiang Feng; Zhao-Xu Zheng; Zheng Wang
Journal:  Asian Pac J Cancer Prev       Date:  2015

4.  Benefits and limits of hepatic resection for gastric metastases.

Authors:  S Ambiru; M Miyazaki; H Ito; K Nakagawa; H Shimizu; H Yoshidome; Y Shimizu; N Nakajima
Journal:  Am J Surg       Date:  2001-03       Impact factor: 2.565

Review 5.  Current status and progress in gastric cancer with liver metastasis.

Authors:  Jing Liu; Lin Chen
Journal:  Chin Med J (Engl)       Date:  2011-02       Impact factor: 2.628

6.  Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.

Authors:  Jung Hun Kang; Soon Il Lee; Do Hyoung Lim; Keon-Woo Park; Sung Yong Oh; Hyuk-Chan Kwon; In Gyu Hwang; Sang-Cheol Lee; Eunmi Nam; Dong Bok Shin; Jeeyun Lee; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Se Hoon Park
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

7.  Chemotherapy and resection for gastric cancer with synchronous liver metastases.

Authors:  Lei Chen; Ming-Quan Song; Hui-Zhong Lin; Lin-Hua Hao; Xiang-Jun Jiang; Zi-Yu Li; Yu-Xin Chen
Journal:  World J Gastroenterol       Date:  2013-04-07       Impact factor: 5.742

8.  Palliative gastrectomy in advanced gastric cancer: is it worthwhile?

Authors:  Inian Samarasam; B Sudhakar Chandran; V Sitaram; Benjamin Perakath; Aravindan Nair; George Mathew
Journal:  ANZ J Surg       Date:  2006 Jan-Feb       Impact factor: 1.872

9.  Effect of intra-hepatoarterial infusion of MMC and CDDP for gastric cancer patients with liver metastases.

Authors:  Y Yonemura; N Matuki; H Sakuma; K Katayama; T Sawa; T Fujimura; S Ohyama; K Miwa; I Miyazaki; M Tanaka
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

10.  Capecitabine and oxaliplatin for advanced esophagogastric cancer.

Authors:  David Cunningham; Naureen Starling; Sheela Rao; Timothy Iveson; Marianne Nicolson; Fareeda Coxon; Gary Middleton; Francis Daniel; Jacqueline Oates; Andrew Richard Norman
Journal:  N Engl J Med       Date:  2008-01-03       Impact factor: 91.245

View more
  1 in total

1.  Prognostic Value of Immunoscore and PD-L1 Expression in Metastatic Colorectal Cancer Patients with Different RAS Status after Palliative Operation.

Authors:  Ruiqi Liu; Ke Peng; Yiyi Yu; Li Liang; Xiaojing Xu; Wei Li; Shan Yu; Tianshu Liu
Journal:  Biomed Res Int       Date:  2018-01-31       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.